Bit Capital Gmb H Concert Pharmaceuticals, Inc. Transaction History

Bit Capital Gmb H

  • $1.26 Trillion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Feb 12, 2025
SELL
$0.0 - $8.4 $0 - $327,600
-39,000 Closed
0 $0
Q4 2022

Feb 12, 2025
SELL
$4.34 - $5.84 $82,460 - $110,960
-19,000 Reduced 32.76%
39,000 $228 Million
Q3 2022

Feb 12, 2025
BUY
$4.27 - $7.2 $247,659 - $417,600
58,000 New
58,000 $389 Million

Others Institutions Holding CNCE

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About CONCERT PHARMACEUTICALS, INC.

CNCE Quotes by TradingView
  • Ticker CNCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,934,600
  • Description
  • Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...
More about CNCE
Track This Portfolio

Track Bit Capital Gmb H Portfolio

Follow Bit Capital Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bit Capital Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Bit Capital Gmb H with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email